Krystal Biotech, Inc. (NASDAQ:KRYS) Receives $222.71 Average Target Price from Brokerages
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) has received an average recommendation of “Buy” from the nine ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on […]
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) has received an average recommendation of “Buy” from the nine ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on […]
